Safety and Tolerability of Combining the IDO-Inhibitor Indoximod with Re-Irradiation for Pediatric Patients with Progressive Brain Tumors Treated on the NLG-2105 Phase 1 Trial (NCT02502708)Theodore Johnson,Dolly Aguilera,Ahmad Al-Basheer,Bree Eaton,Natia Esiashvili,Selim Firat, John Fiveash,Nicholas Foreman,Diana Fridlyand,Gregory Friedman,Cole Giller,David Grosshans,Ian Heger, Michael Kelly,Eugene Kennedy,Ravindra Kolhe,Arthur Liu,William Martin,Waleed Mourad,Rafal Pacholczyk,Rebecca Parker,Amyn Rojiani,Ramses Sadek,Nicholas Vahanian,Tobey Macdonald,David MunnPEDIATRIC BLOOD & CANCER(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要